Nothing Special   »   [go: up one dir, main page]

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (22)

Search Parameters:
Keywords = glomerular cluster

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
13 pages, 1272 KiB  
Article
Machine Learning Approaches for Stroke Risk Prediction: Findings from the Suita Study
by Thien Vu, Yoshihiro Kokubo, Mai Inoue, Masaki Yamamoto, Attayeb Mohsen, Agustin Martin-Morales, Takao Inoué, Research Dawadi and Michihiro Araki
J. Cardiovasc. Dev. Dis. 2024, 11(7), 207; https://doi.org/10.3390/jcdd11070207 - 1 Jul 2024
Viewed by 1553
Abstract
Stroke constitutes a significant public health concern due to its impact on mortality and morbidity. This study investigates the utility of machine learning algorithms in predicting stroke and identifying key risk factors using data from the Suita study, comprising 7389 participants and 53 [...] Read more.
Stroke constitutes a significant public health concern due to its impact on mortality and morbidity. This study investigates the utility of machine learning algorithms in predicting stroke and identifying key risk factors using data from the Suita study, comprising 7389 participants and 53 variables. Initially, unsupervised k-prototype clustering categorized participants into risk clusters, while five supervised models including Logistic Regression (LR), Random Forest (RF), Support Vector Machine (SVM), Extreme Gradient Boosting (XGBoost), and Light Gradient Boosted Machine (LightGBM) were employed to predict stroke outcomes. Stroke incidence disparities among identified risk clusters using the unsupervised k-prototype clustering method are substantial, according to the findings. Supervised learning, particularly RF, was a preferable option because of the higher levels of performance metrics. The Shapley Additive Explanations (SHAP) method identified age, systolic blood pressure, hypertension, estimated glomerular filtration rate, metabolic syndrome, and blood glucose level as key predictors of stroke, aligning with findings from the unsupervised clustering approach in high-risk groups. Additionally, previously unidentified risk factors such as elbow joint thickness, fructosamine, hemoglobin, and calcium level demonstrate potential for stroke prediction. In conclusion, machine learning facilitated accurate stroke risk predictions and highlighted potential biomarkers, offering a data-driven framework for risk assessment and biomarker discovery. Full article
(This article belongs to the Section Stroke and Cerebrovascular Disease)
Show Figures

Figure 1

Figure 1
<p>A flow chart visualizing the model development process.</p>
Full article ">Figure 2
<p>Elbow plot for determining optimal number of clusters. The elbow method for determining the optimal number of clusters in clustering algorithms like k-means involves plotting the Within-Cluster Sum of Squares (WCSS) against the number of clusters (k), and identifying the “elbow point” where adding more clusters does not significantly reduce the WCSS. The elbow point seems to be around k = 3 or k = 4, where the WCSS starts to decrease more slowly.</p>
Full article ">Figure 3
<p>Silhouette plots (with k from 2 (<b>left</b>) to 5 (<b>right</b>)). Silhouette plots show the silhouette coefficient for each sample, which measures how similar a sample is to its own cluster compared to other clusters. Each plot represents a different number of clusters (k). k = 2: the silhouette scores are relatively high, but the plot might indicate that two clusters could be too broad. k = 3: the silhouette scores appear well-distributed with high values, suggesting well-defined clusters. k = 4: the silhouette scores are also relatively high and well-distributed, indicating well-defined clusters. k = 5: the silhouette scores are still good, but there might be a slight decrease compared to k = 3 and k = 4.</p>
Full article ">Figure 4
<p>(<b>left</b>) shows the contribution levels of these variables to stroke incidence, with the width of the red bar representing their global importance. The SHAP value implies the degree of contribution of a specific feature (variable). The higher the SHAP value is, the larger the model contribution of a specific feature. <a href="#jcdd-11-00207-f004" class="html-fig">Figure 4</a> (<b>right</b>), the heat plot of SHAP values reveals the relationships with stroke: red indicates a positive relationship, while blue indicates a negative relationship. Abbreviations: SBP, systolic blood pressure; eGFR, estimated glomerular filtration rate; MetS, metabolic syndrome.</p>
Full article ">
19 pages, 2591 KiB  
Article
Age-Related Changes in Serum N-Glycome in Men and Women—Clusters Associated with Comorbidity
by Óscar Lado-Baleato, Jorge Torre, Róisín O’Flaherty, Manuela Alonso-Sampedro, Iago Carballo, Carmen Fernández-Merino, Carmen Vidal, Francisco Gude, Radka Saldova and Arturo González-Quintela
Biomolecules 2024, 14(1), 17; https://doi.org/10.3390/biom14010017 - 22 Dec 2023
Cited by 2 | Viewed by 1606
Abstract
(1) Aim: To describe, in a general adult population, the serum N-glycome in relation to age in men and women, and investigate the association of N-glycome patterns with age-related comorbidity; (2) Methods: The serum N-glycome was studied by hydrophilic interaction [...] Read more.
(1) Aim: To describe, in a general adult population, the serum N-glycome in relation to age in men and women, and investigate the association of N-glycome patterns with age-related comorbidity; (2) Methods: The serum N-glycome was studied by hydrophilic interaction chromatography with ultra-performance liquid chromatography in 1516 randomly selected adults (55.3% women; age range 18–91 years). Covariates included lifestyle factors, metabolic disorders, inflammatory markers, and an index of comorbidity. Principal component analysis was used to define clusters of individuals based on the 46 glycan peaks obtained in chromatograms; (3) Results: The serum N-glycome changed with ageing, with significant differences between men and women, both in individual N-glycan peaks and in groups defined by common features (branching, galactosylation, sialylation, fucosylation, and oligomannose). Through K-means clustering algorithm, the individuals were grouped into a cluster characterized by abundance of simpler N-glycans and a cluster characterized by abundance of higher-order N-glycans. The individuals of the first cluster were older, showed higher concentrations of glucose and glycation markers, higher levels of some inflammatory markers, lower glomerular filtration rate, and greater comorbidity index; (4) Conclusions: The serum N-glycome changes with ageing with sex dimorphism. The N-glycome could be, in line with the inflammaging hypothesis, a marker of unhealthy aging. Full article
(This article belongs to the Special Issue Protein Glycosylation and Human Diseases)
Show Figures

Figure 1

Figure 1
<p>Glycan peak (GP) abundance in relation to age and sex. For each GP, the mean relative abundance (in percentage) with its 95% confidence interval in men and women was obtained after transforming the data into ilr (isometric log-ratios). The curves were obtained using generalized additive regression models with a predictor factor per curve, estimating a smooth effect of age (using spline functions) for men and women. The adjustments were obtained on the ilr scale and the results were expressed on the real scale after applying its inverse function.</p>
Full article ">Figure 2
<p>Abundance of groups of <span class="html-italic">N-</span>glycans according to their common features: (<b>A</b>) galactosylation (G0 a-, G1 mono-, G2 di-, G3 tri-, and G4 tetragalactosylated); (<b>B</b>) sialylation (S0 a-, S1 mono, S2 di-, S3 tri-, and S4 tretrasialylated) (<b>C</b>) branching (A1 mono-, A2 bi-, A3 tri-, andA4 tetraantennary); (<b>D</b>) fucosylation (core- and outer-arm fucosylation) and oligommannose in relation to age in the men and women. The mean relative abundance (in percentage) is represented, with its 95% confidence interval. The curves were obtained using generalized additive regression models with a predictor factor per curve, estimating a smooth effect of age (using spline functions) for men and women. For galactosylation, branching, and sialylation, the adjustments were obtained on the isometric log-ratio (ilr) scale and the results were expressed on the real scale after applying its inverse function. For fucosylation and oligomannose, the regression response was modelled as a beta distribution variable (bounded between 0 and 1).</p>
Full article ">Figure 3
<p>Principal component analysis (PCA) of the 46 glycan peaks (GPs). (<b>A</b>) Elbow graph to determine the optimal number of groups (clusters). Elbows are observed when the number of groups is 2 and 4. For the present work, two groups (clusters) have been defined. (<b>B</b>) PCA biplot with the clusters defined by K-means of the set of GPs. (<b>C</b>) The 1516 chromatograms with their 46 GPs are represented individually, separated in different colours depending on whether they belong to the cluster 1 or 2, respectively. (<b>D</b>) The means of the 46 GPs in the study population are represented (on a logarithmic scale), separated in different colours depending on whether they belong to cluster 1 or 2, respectively.</p>
Full article ">
17 pages, 2056 KiB  
Article
Exploring Perturbations in Peripheral B Cell Memory Subpopulations Early after Kidney Transplantation Using Unsupervised Machine Learning
by Ariadni Fouza, Anneta Tagkouta, Maria Daoudaki, Maria Stangou, Asimina Fylaktou, Konstantinos Bougioukas, Aliki Xochelli, Lampros Vagiotas, Efstratios Kasimatis, Vasiliki Nikolaidou, Lemonia Skoura, Aikaterini Papagianni, Nikolaos Antoniadis and Georgios Tsoulfas
J. Clin. Med. 2023, 12(19), 6331; https://doi.org/10.3390/jcm12196331 - 1 Oct 2023
Cited by 2 | Viewed by 1274
Abstract
Background: B cells have a significant role in transplantation. We examined the distribution of memory subpopulations (MBCs) and naïve B cell (NBCs) phenotypes in patients soon after kidney transplantation. Unsupervised machine learning cluster analysis is used to determine the association between the cellular [...] Read more.
Background: B cells have a significant role in transplantation. We examined the distribution of memory subpopulations (MBCs) and naïve B cell (NBCs) phenotypes in patients soon after kidney transplantation. Unsupervised machine learning cluster analysis is used to determine the association between the cellular phenotypes and renal function. Methods: MBC subpopulations and NBCs from 47 stable renal transplant recipients were characterized by flow cytometry just before (T0) and 6 months after (T6) transplantation. T0 and T6 measurements were compared, and clusters of patients with similar cellular phenotypic profiles at T6 were identified. Two clusters, clusters 1 and 2, were formed, and the glomerular filtration rate was estimated (eGFR) for these clusters. Results: A significant increase in NBC frequency was observed between T0 and T6, with no statistically significant differences in the MBC subpopulations. Cluster 1 was characterized by a predominance of the NBC phenotype with a lower frequency of MBCs, whereas cluster 2 was characterized by a high frequency of MBCs and a lower frequency of NBCs. With regard to eGFR, cluster 1 showed a higher value compared to cluster 2. Conclusions: Transplanted kidney patients can be stratified into clusters based on the combination of heterogeneity of MBC phenotype, NBCs and eGFR using unsupervised machine learning. Full article
(This article belongs to the Special Issue Recent Advances of Kidney Transplantation: Part II)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Flow chart of the study design.</p>
Full article ">Figure 2
<p>Frequencies of B cells (<b>A</b>), naïve B cells (<b>B</b>), Double negative B cells (<b>C</b>) and marginal zone B cells, peripheral equivalent (<b>D</b>) at T0 (pre-transplant) and T6 (6 months post-transplant). Frequencies of total memory B lymphocytes (<b>E</b>), class-switched (<b>F</b>), class non-switched (<b>G</b>) memory B cells at T0 (pre-transplant) and T6 (6 months post-transplant).</p>
Full article ">Figure 2 Cont.
<p>Frequencies of B cells (<b>A</b>), naïve B cells (<b>B</b>), Double negative B cells (<b>C</b>) and marginal zone B cells, peripheral equivalent (<b>D</b>) at T0 (pre-transplant) and T6 (6 months post-transplant). Frequencies of total memory B lymphocytes (<b>E</b>), class-switched (<b>F</b>), class non-switched (<b>G</b>) memory B cells at T0 (pre-transplant) and T6 (6 months post-transplant).</p>
Full article ">Figure 3
<p>The dendrogram of the proportion model: the structure of the final hierarchy and the two clusters, represented by rectangles, that separate the 10 patients from the 37 patients (left; cluster 2, right; cluster 1).</p>
Full article ">Figure 4
<p>Comparisons of cell frequencies between clusters 1 and 2. (<b>A</b>). The two clusters differed in NBCs, of which cluster 1 had 74.3% and cluster 2 had 50% <span class="html-italic">p</span> &lt; 0.001 (<b>B</b>). The TMBCs showed a difference between the two clusters, with cluster 1 having the lowest percentage with a median of 23.8% and cluster 2 with 49.9% <span class="html-italic">p</span> &lt; 0.001. (<b>C</b>). Switched memory B cells (SBM) cells differ between the two clusters. Cluster 2 has the highest percentages (median percentage of 21.5) while cluster 1 has the lowest percentages (median percentage of 13) <span class="html-italic">p =</span> 0.004. (<b>D</b>). Non-switched memory B cells (NSBM) are different in cluster 1 and cluster 2, with the median percentage of 9 in cluster 1 and a median of 24 in cluster 2 (<span class="html-italic">p</span> &lt; 0.001). (<b>E</b>). DN cells do not reach significant different levels between the two clusters (<span class="html-italic">p</span> = 0.125).</p>
Full article ">Figure 5
<p>Bar plots showing the distribution of cells in each cluster. The length of each rectangle is calculated as the proportion of the total score of that variable in the cluster. Double negative (with memory properties) cells: DNMBCs, peripheral equivalent to marginal zone B cells: MZBCs, naïve B cells: NBCs, class non-switched memory B cells: NSMBCs, class-switched memory B cells: SMBCs, total memory B cells: TMBCs.</p>
Full article ">Figure 6
<p>Heatmap of patient distribution at intra-cluster level. The heatmap matrix is constructed by all B cell subpopulations of our proportion model in its rows and the renal transplant recipients in its columns. Z-scaled scores of all the variables for each patient in our model are represented by colour grading. The first ten observations are the 10 patients of cluster 2 (patient 1 to patient 10), while the remaining 37 patients belong to cluster 1 (patient 11 to patient 47). Naïve B cells: NBCs, peripheral equivalent to marginal zone B cells: MZBCs, double negative with memory properties cells: DNMBCs, class non-switched memory B cells: NSMBCs, class-switched memory B cells: SMBCs, total memory B cells: TMBCs, pt: patient.</p>
Full article ">Figure 7
<p>Boxplots of eGFR of the patients in clusters with median values of each cluster (median 1, median 2). Overall data median was also estimated and depicted with the horizontal intermittent red line (overall data median, cutoff). Overall data maximum belongs to cluster 1 (overall data max) while overall data minimum belongs to cluster 2 (overall data min). Patients are shown as points. Green points represent patients with eGFR value above or equal with overall median and blue points represent patients with eGFR value below overall median.</p>
Full article ">
11 pages, 817 KiB  
Article
Role of Cardio-Renal Dysfunction, Inflammation Markers, and Frailty on In-Hospital Mortality in Older COVID-19 Patients: A Cluster Analysis
by Francesco Spannella, Federico Giulietti, Giorgia Laureti, Mirko Di Rosa, Chiara Di Pentima, Massimiliano Allevi, Caterina Garbuglia, Piero Giordano, Matteo Landolfo, Letizia Ferrara, Alessia Fumagalli, Fabrizia Lattanzio, Anna Rita Bonfigli and Riccardo Sarzani
Biomedicines 2023, 11(9), 2473; https://doi.org/10.3390/biomedicines11092473 - 6 Sep 2023
Cited by 2 | Viewed by 1359
Abstract
Our study aimed to identify clusters of hospitalized older COVID-19 patients according to their main comorbidities and routine laboratory parameters to evaluate their association with in-hospital mortality. We performed an observational study on 485 hospitalized older COVID-19 adults (aged 80+ years). Patients were [...] Read more.
Our study aimed to identify clusters of hospitalized older COVID-19 patients according to their main comorbidities and routine laboratory parameters to evaluate their association with in-hospital mortality. We performed an observational study on 485 hospitalized older COVID-19 adults (aged 80+ years). Patients were aggregated in clusters by a K-medians cluster analysis. The primary outcome was in-hospital mortality. Medical history and laboratory parameters were collected on admission. Frailty, defined by the Clinical Frailty Scale (CFS), referred to the two weeks before hospitalization and was used as a covariate. The median age was 87 (83–91) years, with a female prevalence (59.2%). Three different clusters were identified: cluster 1 (337), cluster 2 (118), and cluster 3 (30). In-hospital mortality was 28.5%, increasing from cluster 1 to cluster 3: cluster 1 = 21.1%, cluster 2 = 40.7%, and cluster 3 = 63.3% (p < 0.001). The risk for in-hospital mortality was higher in clusters 2 [HR 1.96 (95% CI: 1.28–3.01)] and 3 [HR 2.87 (95% CI: 1.62–5.07)] compared to cluster 1, even after adjusting for age, sex, and frailty. Patients in cluster 3 were older and had a higher prevalence of atrial fibrillation, higher admission NT-proBNP and C-reactive protein levels, higher prevalence of concurrent bacterial infections, and lower estimated glomerular filtration rates. The addition of CFS significantly improved the predictive ability of the clusters for in-hospital mortality. Our cluster analysis on older COVID-19 patients provides a characterization of those subjects at higher risk for in-hospital mortality, highlighting the role played by cardio-renal impairment, higher inflammation markers, and frailty, often simultaneously present in the same patient. Full article
(This article belongs to the Special Issue Emerging Trends in COVID-19 and Heart Failure)
Show Figures

Figure 1

Figure 1
<p>Log-rank test for equality of survivor functions: χ<sup>2</sup> = 30.01; <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 2
<p>Accuracy comparison for Cluster and CFS.</p>
Full article ">
17 pages, 2005 KiB  
Article
Implications in Halotherapy of Aerosols from the Salt Mine Targu Ocna—Structural-Functional Characteristics
by Mihaela Orlanda Antonovici (Munteanu), Ioan Gabriel Sandu, Viorica Vasilache, Andrei Victor Sandu, Stefanita Arcana, Raluca Ioana Arcana and Ion Sandu
Healthcare 2023, 11(14), 2104; https://doi.org/10.3390/healthcare11142104 - 24 Jul 2023
Cited by 2 | Viewed by 1238
Abstract
The paper presents the evolution of the concentration level for four particle size groups of microaerosols (1.0, 2.5, 4.0 and 10.0 µm) in correlation with the microclimatic characteristics (temperature, humidity, lighting, pressure and concentration in CO2 and O2) in three [...] Read more.
The paper presents the evolution of the concentration level for four particle size groups of microaerosols (1.0, 2.5, 4.0 and 10.0 µm) in correlation with the microclimatic characteristics (temperature, humidity, lighting, pressure and concentration in CO2 and O2) in three active areas of the Targu Ocna Saltworks, currently used in treatments with solions (hydrated aerosols): in the vicinity of the walls of the old mining salt room, where there is a semi-wet static regime (SSR); in the transition area between the old rooms of exploitation with the semi-wet dynamic regime (DSR); and in the area of the waterfall and the marshy lake with the dynamic wet regime (DWR). The first and last halochamber are the ones recommended for cardio–respiratory, immuno–thyroid and osteo–muscular conditions, as well as in psycho–motor disorders. Based on questionnaires carried out over the course of a year, between 1 September 2021–31 August 2022, in two periods of stationing/treatment: a cold one (15 September 2021–15 December 2021) and a warm one (1 May 2022–30 July 2022), correlated with the data from the Salina medical office, achieved the profile of the improvement rate of the patients’ ailments depending on the type of treatment (working regime in halochambers). These studies have allowed the optimization of the treatment conditions in the artificial surface halochambers in order to reduce the stationary period and optimize the treatment cycles. Full article
Show Figures

Figure 1

Figure 1
<p>Old exploitation room. Halochamber with semi-wet static mode. Area with training and fitness equipment (acquisition of microclimate data at the level of the salt wall).</p>
Full article ">Figure 2
<p>Corridor between the old exploitation rooms. Halochamber with semi-wet static regime (retrieving microclimate data from the center of the transition corridor).</p>
Full article ">Figure 3
<p>Saltwater lake and waterfall: (<b>a</b>) halochamber with wet dynamic mode; (<b>b</b>) detail with the waterfall area.</p>
Full article ">Figure 4
<p>The model of the questionnaire registered for the two analyzed periods (15 September 2021–15 December 2021 and 1 May 2022–30 July 2022) the patients, athletes and tourists present in Salina Tg. Ocna.</p>
Full article ">
25 pages, 10680 KiB  
Article
Emerging Perspectives on the Rare Tubulopathy Dent Disease: Is Glomerular Damage a Direct Consequence of ClC-5 Dysfunction?
by Giovanna Priante, Monica Ceol, Lisa Gianesello, Dario Bizzotto, Paola Braghetta, Lorenzo Arcangelo Calò, Dorella Del Prete and Franca Anglani
Int. J. Mol. Sci. 2023, 24(2), 1313; https://doi.org/10.3390/ijms24021313 - 9 Jan 2023
Cited by 5 | Viewed by 2166
Abstract
Dent disease (DD1) is a rare tubulopathy caused by mutations in the CLCN5 gene. Glomerulosclerosis was recently reported in DD1 patients and ClC-5 protein was shown to be expressed in human podocytes. Nephrin and actin cytoskeleton play a key role for podocyte functions [...] Read more.
Dent disease (DD1) is a rare tubulopathy caused by mutations in the CLCN5 gene. Glomerulosclerosis was recently reported in DD1 patients and ClC-5 protein was shown to be expressed in human podocytes. Nephrin and actin cytoskeleton play a key role for podocyte functions and podocyte endocytosis seems to be crucial for slit diaphragm regulation. The aim of this study was to analyze whether ClC-5 loss in podocytes might be a direct consequence of the glomerular damage in DD1 patients. Three DD1 kidney biopsies presenting focal global glomerulosclerosis and four control biopsies were analyzed by immunofluorescence (IF) for nephrin and podocalyxin, and by immunohistochemistry (IHC) for ClC-5. ClC-5 resulted as down-regulated in DD1 vs. control (CTRL) biopsies in both tubular and glomerular compartments (p < 0.01). A significant down-regulation of nephrin (p < 0.01) in DD1 vs. CTRL was demonstrated. CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/Caspase9) gene editing of CLCN5 in conditionally immortalized human podocytes was used to obtain clones with the stop codon mutation p.(R34Efs*14). We showed that ClC-5 and nephrin expression, analyzed by quantitative Reverse Transcription/Polymerase Chain Reaction (qRT/PCR) and In-Cell Western (ICW), was significantly downregulated in mutant clones compared to the wild type ones. In addition, F-actin staining with fluorescent phalloidin revealed actin derangements. Our results indicate that ClC-5 loss might alter podocyte function either through cytoskeleton disorganization or through impairment of nephrin recycling. Full article
Show Figures

Figure 1

Figure 1
<p>Immunofluorescence (IF) in serial sections of glomeruli showing the expression pattern of nephrin and podocalyxin in control (CTRL) and Dent Disease 1 (DD1) kidneys biopsies. (<b>A</b>): Representative image disclosing the absence of nephrin positivity in DD1 glomeruli while podocalyxin immunolabeling was present in both CTRL and DD1 glomeruli. Green: Nephrin; Blue: DAPI. Images were acquired using a DMI6000CS-TCS SP8 fluorescence microscope (Leica Microystems, Wetzlar, Germany) with 20×/0.4 objective. Scale bar 25 μm. (<b>B</b>): Morphometric evaluation of nephrin and podocalixin IF in CTRL and DD1 glomeruli. Boxplots show IF staining scores (% positive area).</p>
Full article ">Figure 2
<p><span class="html-italic">CLCN5</span> gene and protein expression in WT and <span class="html-italic">CLCN5</span><sup>−/−</sup> clones. Boxplots show (<b>A</b>,<b>B</b>) relative mRNA, as determined by qRT-PCR and (<b>C</b>,<b>D</b>) protein expression, as determined by ICW analysis. <span class="html-italic">p</span>-values were obtained with the Mann–Whitney U test. Results are from two independent experiments performed in triplicate. Abbreviations: nRQ: normalized relative quantity; OD, optical density.</p>
Full article ">Figure 3
<p>Qualitative RT-PCR analysis of canonical <span class="html-italic">CLCN5</span>-204 isoform mRNA. Image generated by Agilent 2100 bioanalyzer of amplified exon 2 in <span class="html-italic">CLCN5<sup>−/−</sup></span> (lines 1 and 2) and WT clones (lines 3, 4, and 5).</p>
Full article ">Figure 4
<p>Qualitative RT-PCR analysis of <span class="html-italic">CLCN5</span>-206 isoform mRNA. Images generated by Agilent 2100 bioanalyzer of amplified housekeeping gene (glyceraldehyde 3-phosphate dehydrogenase—<span class="html-italic">GAPDH</span>) and <span class="html-italic">CLCN5</span>-206 isoform in (<b>A</b>) different human kidney cell lines, and (<b>B</b>) in <span class="html-italic">CLCN5<sup>−/−</sup></span> (Lines 1 and 2) and WT clones (Lines 3, 4, and 5). Chromatograms refer to <span class="html-italic">CLCN5</span>-206 isoform amplicons. Images are representative of three independent experiments.</p>
Full article ">Figure 5
<p>Nephrin gene (<span class="html-italic">NHPS1</span>) and protein expression in WT and <span class="html-italic">CLCN5</span><sup>−/−</sup> clones. Boxplots show (<b>A</b>,<b>B</b>) relative mRNA, as determined by qRT-PCR, and (<b>C</b>,<b>D</b>) protein expression, as determined by ICW. <span class="html-italic">p</span>-values were obtained with the Mann-Whitney U test. Results are from two independent experiments performed in triplicate. Abbreviations: nRQ: normalized relative quantity; OD, optical density.</p>
Full article ">Figure 6
<p>Phalloidin fluorescence labelling of F-actin of human podocytes, WT, and <span class="html-italic">CLCN5<sup>−/−</sup></span> clones. Representative images (with boxed photos showing zoomed-in area) demonstrating: (<b>A</b>) no difference in the staining pattern between human podocytes and WT clones, while irregular F-actin distribution in <span class="html-italic">CLCN5</span><sup>−/−</sup> clones was markedly present; (<b>B</b>) differences in the staining pattern between heterozygous (<span class="html-italic">CLCN5</span><sup>+/−</sup>) and homozygous (<span class="html-italic">CLCN5</span><sup>−/−</sup>) clones: actin cytoskeleton alteration of heterozygous clones was intermediate between normal human podocytes and homozygous clones. Red: actin; Blue: DAPI. Images were acquired using a DMI6000CS-TCS SP8 fluorescence microscope (Leica Microystems, Wetzlar, Germany) with 20×/0.4 objective. Fluorescence microscope images are representative of three independent experiments. Merge: merge with DAPI. Scale bar 25 μm.</p>
Full article ">Figure 7
<p>Cell viability assessment. Results of methylene blue assay of WT and <span class="html-italic">CLCN5</span><sup>−/−</sup> cells treated with albumin (range 10 µg/mL–30 mg/mL) for 48 and 72 h. <span class="html-italic">p</span>-values were obtained with the Mann-Whitney U test. The results presented are from two independent experiments performed in triplicate. * <span class="html-italic">p</span> &lt; 0.001; § <span class="html-italic">p</span> &lt; 0.005; # <span class="html-italic">p</span> &lt; 0.01; <span>$</span> <span class="html-italic">p</span> &lt; 0.05. OD: optical density. CTR: unstimulated cells.</p>
Full article ">Figure 8
<p>ClC-5, ClC-3, and ClC-4 expression in control WT and <span class="html-italic">CLCN5</span><sup>−/−</sup> clones following albumin treatment. Boxplots shows medians and interquartile ranges of (<b>A</b>) relative <span class="html-italic">CLCN5</span> mRNA, as determined by qRT-PCR, and ClC-5 (<b>B</b>), ClC-3 (<b>C</b>), and ClC-4 (<b>D</b>) protein expression as determined by ICW. <span class="html-italic">p</span>-values were obtained with the Mann–Whitney U test. * <span class="html-italic">p</span> &lt; 0.001; § <span class="html-italic">p</span> &lt; 0.005; <span>$</span> <span class="html-italic">p</span> &lt; 0.05. Results are from two independent experiments performed in triplicate (qRT-PCR) and in quadruplicate (ICW). Abbreviations: nRQ: normalized relative quantity; OD, optical density, CTR: unstimulated cells.</p>
Full article ">Figure 9
<p>Qualitative RT-PCR analysis of the <span class="html-italic">CLCN5</span>-206 isoform mRNA. Image generated by the Agilent 2100 bioanalyzer of amplified housekeeping gene (glyceraldehyde 3-phosphate dehydrogenase—<span class="html-italic">GAPDH</span>) and <span class="html-italic">CLCN5</span>-206 isoform in <span class="html-italic">CLCN5<sup>−/−</sup></span> (Lines 1 to 4: lines 1–2 CTR, lines 3–4 30 mg/mL of albumin after 48 h of exposure) and WT clones (Lines 5 to 8: lines 5–6 CTRL, lines 7–8 30 mg/mL of albumin after 48 h of exposure). Chromatograms refer to <span class="html-italic">CLCN5</span>-206 isoform amplicons. Image is representative of the results of three independent experiments.</p>
Full article ">Figure 10
<p>Nephrin expression in WT and <span class="html-italic">CLCN5</span><sup>−/−</sup> clones following albumin treatment (10 mg/mL and 30 mg/mL) at different time points (24, 48, and 72 h). Boxplots show medians and interquartile ranges of (<b>A</b>) protein expression, as determined by ICW and (<b>B</b>) relative mRNA, as determined by qRT-PCR. <span class="html-italic">p</span>-values were obtained with the Mann–Whitney U test. * <span class="html-italic">p</span> &lt; 0.001; # <span class="html-italic">p</span> &lt; 0.01; <span>$</span> <span class="html-italic">p</span> &lt; 0.05. Results are from two independent experiments performed in triplicate (RT-PCR) and in quadruplicate (ICW). Abbreviations: nRQ: normalized relative quantity; OD, optical density.</p>
Full article ">Figure 11
<p>Cubilin expression in WT and <span class="html-italic">CLCN5</span><sup>−/−</sup> clones following albumin treatment (10 mg/mL and 30 mg/mL) at different time points (24, 48, and 72 h). Boxplots show medians and interquartile ranges of (<b>A</b>) relative mRNA, as determined by qRT-PCR, and (<b>B</b>) protein expression, as determined by ICW. <span class="html-italic">p</span>-values were obtained with the Mann–Whitney U test. * <span class="html-italic">p</span> &lt; 0.001; § <span class="html-italic">p</span> &lt; 0.005; # <span class="html-italic">p</span> &lt; 0.01; <span>$</span> <span class="html-italic">p</span> &lt; 0.05. Results are from two independent experiments performed in triplicate (qRT-PCR) and in quadruplicate (ICW). Abbreviations: nRQ: normalized relative quantity; OD, optical density.</p>
Full article ">Figure 12
<p>Phalloidin fluorescence labelling of F-actin of human podocytes, WT (clones subjected to CRISPR/Cas9 editing but without mutation), and mutant clones (<span class="html-italic">CLCN5</span><sup>−/−</sup>) after exposure to albumin 30 mg/mL for 72 h. Representative images with boxed photos showing zoomed-in area demonstrating no differences in the F-actin staining pattern of <span class="html-italic">CLCN5</span><sup>−/−</sup> mutant between CTR and albumin treatment. Alterations of F-staining pattern in WT clones and in human podocytes under albumin treatment were observed. Red: actin; Blue: DAPI. Images were acquired using a DMI6000CS-TCS SP8 fluorescence microscope (Leica Microystems, Wetzlar, Germany) with 20×/0.4 objective. Fluorescence microscope images are representative of three independent experiments. Scale bar 25 μm.</p>
Full article ">Figure 13
<p>Schematic representation of primer localization in <span class="html-italic">CLCN5</span> cDNA. Primer pairs 1F-4R amplify canonical <span class="html-italic">CLCN5</span>-204 isoform; primer pairs nested 206F-nested 206R amplify only <span class="html-italic">CLCN5</span>-206 isoform starting from a primary amplicon obtained by a first PCR amplification with primer pairs 8F-10R.</p>
Full article ">
10 pages, 339 KiB  
Article
Analysis of the Association between Metabolic Syndrome and Renal Function in Middle-Aged Patients with Diabetes
by Yoonjin Park and Su Jung Lee
Int. J. Environ. Res. Public Health 2022, 19(18), 11832; https://doi.org/10.3390/ijerph191811832 - 19 Sep 2022
Cited by 3 | Viewed by 2184
Abstract
This study investigated the effects of metabolic syndrome on the estimated glomerular filtration rate in middle-aged participants with diabetes to provide basic data to enable the development of education programs for middle-aged people to prevent diabetic kidney disease. This cross-sectional descriptive study analyzed [...] Read more.
This study investigated the effects of metabolic syndrome on the estimated glomerular filtration rate in middle-aged participants with diabetes to provide basic data to enable the development of education programs for middle-aged people to prevent diabetic kidney disease. This cross-sectional descriptive study analyzed data obtained in the 2nd year of the 8th Korea National Health and Nutrition Examination Survey in 2020 and enrolled 279 participants aged 40–65 years who were diagnosed with diabetes. Multilevel stratified cluster sampling was used to improve the representativeness of the samples and the accuracy of parameter estimation. The risk factors of metabolic syndrome and the risk of elevated eGFR were analyzed using regression analysis and the correlation between the variables was determined using Pearson’s correlation analysis. Middle-aged participants with diabetes whose eGFR was <90 showed a significant difference in their risk for metabolic syndrome based on sex, age, disease duration, and total cholesterol concentrations. Systolic blood pressure and waist circumference in men, and waist circumference and HDL cholesterol level in women were identified as risk factors that contribute to the increasing prevalence of metabolic syndrome. Full article
(This article belongs to the Topic Metabolism and Health)
25 pages, 3475 KiB  
Article
Natural Language Processing in Diagnostic Texts from Nephropathology
by Maximilian Legnar, Philipp Daumke, Jürgen Hesser, Stefan Porubsky, Zoran Popovic, Jan Niklas Bindzus, Joern-Helge Heinrich Siemoneit and Cleo-Aron Weis
Diagnostics 2022, 12(7), 1726; https://doi.org/10.3390/diagnostics12071726 - 15 Jul 2022
Cited by 7 | Viewed by 3016
Abstract
Introduction: This study investigates whether it is possible to predict a final diagnosis based on a written nephropathological description—as a surrogate for image analysis—using various NLP methods. Methods: For this work, 1107 unlabelled nephropathological reports were included. (i) First, after separating each report [...] Read more.
Introduction: This study investigates whether it is possible to predict a final diagnosis based on a written nephropathological description—as a surrogate for image analysis—using various NLP methods. Methods: For this work, 1107 unlabelled nephropathological reports were included. (i) First, after separating each report into its microscopic description and diagnosis section, the diagnosis sections were clustered unsupervised to less than 20 diagnostic groups using different clustering techniques. (ii) Second, different text classification methods were used to predict the diagnostic group based on the microscopic description section. Results: The best clustering results (i) could be achieved with HDBSCAN, using BoW-based feature extraction methods. Based on keywords, these clusters can be mapped to certain diagnostic groups. A transformer encoder-based approach as well as an SVM worked best regarding diagnosis prediction based on the histomorphological description (ii). Certain diagnosis groups reached F1-scores of up to 0.892 while others achieved weak classification metrics. Conclusion: While textual morphological description alone enables retrieving the correct diagnosis for some entities, it does not work sufficiently for other entities. This is in accordance with a previous image analysis study on glomerular change patterns, where some diagnoses are associated with one pattern, but for others, there exists a complex pattern combination. Full article
(This article belongs to the Special Issue Artificial Intelligence in Pathological Image Analysis)
Show Figures

Figure 1

Figure 1
<p>Flowchart, describing the general procedure of the project. After splitting each nephropathological report into its diagnosis and description section (data preparation), we first applied the clustering task (i) to the diagnosis texts in order to summarize them into less than 20 clusters. After labelling each cluster of diagnosis texts with a corresponding diagnostic group, we applied the classification task (ii) to the description texts in order to find out if it’s possible to predict the correct diagnostic group of a given description text with NLP techniques.</p>
Full article ">Figure 2
<p><b>UMAP!</b> (<b>UMAP!</b>) and <b>PCA!</b> (<b>PCA!</b>) of different cluster-sets. UMAP representations of the cluster-sets generated with (<b>a</b>) <b>LDA!</b> (<b>LDA!</b>), (<b>c</b>) <b>HDBSCAN!</b> (<b>HDBSCAN!</b>), (<b>d</b>) top2vec, (<b>e</b>) German-BERT, (<b>f</b>) Patho-BERT, (<b>g</b>) k-means and (<b>h</b>) <b>GSDPMM!</b> (<b>GSDPMM!</b>). The <b>LDA!</b> cluster-set is also shown as <b>PCA!</b> (<b>PCA!</b>) in (<b>b</b>). Each data point represents a diagnosis section of a report. The data points are coloured according to the respective clusters. Black points represent outliers that were not assigned to any cluster. Above all, the clusters of top2vec and <b>HDBSCAN!</b> appear particularly tidy and separated. The clusters of k-means and <b>GSDPMM!</b> appear less well separated, which is probably also due to the fact that no data points are sorted out here.</p>
Full article ">Figure 3
<p>Confusion matrices of the classification models. (<b>a</b>) German-BERT, (<b>b</b>) Patho-BERT, (<b>c</b>) the <b>SVM!</b> (<b>SVM!</b>)-based SGD-classifier, and (<b>d</b>) the <b>MLP! (MLP!)</b>-classifier. The brightness of a cell indicates how many times the class on the x-axis was predicted by the classifier. The true class is indicated by the index of the y-axis. Interestingly, there are classes that could be recognized well by all classifiers, including the weaker ones, e.g., class 1 (<span class="html-italic">rapid progressive glomerulonephritis</span>), 2 (<span class="html-italic">tubulo-interstitial nephritis</span>) and 3 (<span class="html-italic">pauci immune glomerulonephritis</span>). Although the transformer-based classifiers (<b>a</b>,<b>b</b>) generally performed better, the <b>BoW!</b>-based methods were able to detect class 0 (<span class="html-italic">systemic lupus erythematosus</span>) or 5 (<span class="html-italic">fsgn</span>) better (<b>c</b>,<b>d</b>).</p>
Full article ">Figure A1
<p><b>UMAP!</b> (<b>UMAP!</b>) of the cluster-sets generated with (<b>a</b>) <b>LDA!</b> (<b>LDA!</b>), (<b>c</b>) <b>HDBSCAN!</b> (<b>HDBSCAN!</b>), (<b>d</b>) top2vec, (<b>e</b>) German-BERT, (<b>f</b>) Patho-BERT, (<b>g</b>) k-means and (<b>h</b>) <b>GSDPMM!</b> (<b>GSDPMM!</b>). The <b>LDA!</b> (<b>LDA!</b>) cluster-set is also shown as <b>PCA!</b> (<b>PCA!</b>) in (<b>b</b>). Each dot colour represents a different author. The authors of the reports marked in black are unknown (e.g. because multiple authors were involved).</p>
Full article ">
16 pages, 2565 KiB  
Article
Distinct Subtyping of Successful Weaning from Acute Kidney Injury Requiring Renal Replacement Therapy by Consensus Clustering in Critically Ill Patients
by Heng-Chih Pan, Chiao-Yin Sun, Thomas Tao-Min Huang, Chun-Te Huang, Chun-Hao Tsao, Chien-Heng Lai, Yung-Ming Chen and Vin-Cent Wu
Biomedicines 2022, 10(7), 1628; https://doi.org/10.3390/biomedicines10071628 - 7 Jul 2022
Cited by 4 | Viewed by 1934
Abstract
Background: Clinical decisions regarding the appropriate timing of weaning off renal replacement therapy (RRT) in critically ill patients are complex and multifactorial. The aim of the current study was to identify which critical patients with acute kidney injury (AKI) may be more likely [...] Read more.
Background: Clinical decisions regarding the appropriate timing of weaning off renal replacement therapy (RRT) in critically ill patients are complex and multifactorial. The aim of the current study was to identify which critical patients with acute kidney injury (AKI) may be more likely to be successfully weaned off RRT using consensus cluster analysis. Methods: In this study, critically ill patients who received RRT at three multicenter referral hospitals at several timepoints from August 2016 to July 2018 were enrolled. An unsupervised consensus clustering algorithm was used to identify distinct phenotypes. The outcomes of interest were the ability to wean off RTT and 90-day mortality. Results: A total of 124 patients with AKI requiring RRT (AKI-RRT) were enrolled. The 90-day mortality rate was 30.7% (38/124), and 49.2% (61/124) of the patients were successfully weaned off RRT for over 90 days. The consensus clustering algorithm identified three clusters from a total of 45 features. The three clusters had distinct features and could be separated according to the combination of urinary neutrophil gelatinase-associated lipocalin to creatinine ratio (uNGAL/Cr), Sequential Organ Failure Assessment (SOFA) score, and estimated glomerular filtration rate at the time of weaning off RRT. uNGAL/Cr (hazard ratio [HR] 2.43, 95% confidence interval [CI]: 1.36–4.33) and clustering phenotype (cluster 1 vs. 3, HR 2.7, 95% CI: 1.11–6.57; cluster 2 vs. 3, HR 44.5, 95% CI: 11.92–166.39) could predict 90-day mortality or re-dialysis. Conclusions: Almost half of the critical patients with AKI-RRT could wean off dialysis for over 90 days. Urinary NGAL/Cr and distinct clustering phenotypes could predict 90-day mortality or re-dialysis. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Consensus clustering analysis results displaying the robustness of sample classification using multiple iterations of k-means clustering. (<b>A</b>–<b>D</b>) The consensus matrix heat maps of K = 3, 4, 5 to K = 6 using 45 baseline parameters. The dark blue color shows the consensus of which groups fit perfectly together, and the white color shows that two individuals are always grouped separately. (<b>E</b>) Curve of CDF. (<b>F</b>) CDF delta area curve of consensus clustering. The <span class="html-italic">x</span> axis represents the category k, and the y axis denotes the relative change in area under the CDF curve of category k compared with category k − 1. <b>Abbreviations:</b> CDF, cumulative distribution function.</p>
Full article ">Figure 2
<p>(<b>A</b>) <b>The heatmap shows the three subtypes according to the selected baseline parameters.</b> The dendrogram on the y axis shows consensus clustering of the patients. The x axis shows the variables of the patients attempting to wean from RRT. (<b>B</b>) <b>Correlations between baseline predictors with overall mortality.</b> Generalized pairs plot depicting all of the pairwise scatter plots comparing scores of each pair of selected predictors (upper diagonal), and the regression line (lower diagonal). Each plotted point represents a study participant. Distributions and plots are based on values for the area under the positive part of the curve which are displayed on the axes; the shaded areas show 95% confidence intervals, and significant differences are represented by asterisks. Red boxes represent significant correlations of baseline eGFR and eGFR when stopping dialysis. <b>Abbreviations:</b> BUN, blood urea nitrogen; Cr, Creatinine; eGFR, estimated glomerular filtration rate; NGAL, neutrophil gelatinase-associated lipocalin; RRT, renal replacement therapy; sCr, serum creatinine; SOFA, Sequential Organ Failure Assessment; UO, urine output.</p>
Full article ">Figure 3
<p>(<b>A</b>) <b>Circular barplots of the selected predictors associated with each cluster.</b> The height of each bar represents each percentage of standard difference to total standard difference response of each characteristic. (<b>B</b>) <b>Three clusters based on 18 parameters</b>. Manhattan plot of the standardized differences across three AKI subgroups of the selected baseline predictors. The x axis is the standardized difference value, and the y axis represents the four time serial baseline parameters. The dashed-dotted vertical lines represent standardized difference cutoffs of &gt;0.3 or &lt;−0.3. The light blue horizontal lines sort the category to which the predictors belong, including T1 (baseline), T2 (before initiating RRT), T3 (at the time of stopping RRT) and T4 (24 h after weaning off RRT). <b>Abbreviations:</b> AKI, acute kidney injury; BUN, blood urea nitrogen; Cr, creatinine; eGFR, estimated glomerular filtration rate; NGAL, neutrophil gelatinase-associated lipocalin; RRT, renal replacement therapy; sCr, serum creatinine; SOFA, Sequential Organ Failure Assessment; UO, urine output.</p>
Full article ">Figure 4
<p>Kaplan–Meier survival plots of the three cluster groups defined by all predictors and (<b>A</b>) 90-day mortality. (<b>B</b>) Composite outcome of 90-day mortality or re-dialysis. The log rank <span class="html-italic">p</span> values for all comparisons were &lt;0.001.</p>
Full article ">Figure 5
<p>3D scatter plot of patients with colors representing clustering by eGFR, SOFA score and uNGAL/Cr (log) at the time of weaning off RRT. <b>Abbreviations:</b> Cr, creatinine; eGFR, estimated glomerular filtration rate; RRT, renal replacement therapy; SOFA, Sequential Organ Failure Assessment; uNGAL, urinary neutrophil gelatinase-associated lipocalin.</p>
Full article ">
29 pages, 3423 KiB  
Article
Lysophosphatidic Acid Is a Proinflammatory Stimulus of Renal Tubular Epithelial Cells
by Christiana Magkrioti, Georgia Antonopoulou, Dionysios Fanidis, Vaia Pliaka, Theodore Sakellaropoulos, Leonidas G. Alexopoulos, Christoph Ullmer and Vassilis Aidinis
Int. J. Mol. Sci. 2022, 23(13), 7452; https://doi.org/10.3390/ijms23137452 - 5 Jul 2022
Cited by 6 | Viewed by 3080
Abstract
Chronic kidney disease (CKD) refers to a spectrum of diseases defined by renal fibrosis, permanent alterations in kidney structure, and low glomerular-filtration rate. Prolonged epithelial-tubular damage involves a series of changes that eventually lead to CKD, highlighting the importance of tubular epithelial cells [...] Read more.
Chronic kidney disease (CKD) refers to a spectrum of diseases defined by renal fibrosis, permanent alterations in kidney structure, and low glomerular-filtration rate. Prolonged epithelial-tubular damage involves a series of changes that eventually lead to CKD, highlighting the importance of tubular epithelial cells in this process. Lysophosphatidic acid (LPA) is a bioactive lipid that signals mainly through its six cognate LPA receptors and is implicated in several chronic inflammatory pathological conditions. In this report, we have stimulated human proximal tubular epithelial cells (HKC-8) with LPA and 175 other possibly pathological stimuli, and simultaneously detected the levels of 27 intracellular phosphoproteins and 32 extracellular secreted molecules with multiplex ELISA. This quantification revealed a large amount of information concerning the signaling and the physiology of HKC-8 cells that can be extrapolated to other proximal tubular epithelial cells. LPA responses clustered with pro-inflammatory stimuli such as TNF and IL-1, promoting the phosphorylation of important inflammatory signaling hubs, including CREB1, ERK1, JUN, IκΒα, and MEK1, as well as the secretion of inflammatory factors of clinical relevance, including CCL2, CCL3, CXCL10, ICAM1, IL-6, and IL-8, most of them shown for the first time in proximal tubular epithelial cells. The identified LPA-induced signal-transduction pathways, which were pharmacologically validated, and the secretion of the inflammatory factors offer novel insights into the possible role of LPA in CKD pathogenesis. Full article
Show Figures

Figure 1

Figure 1
<p>Multiplex ELISA for the detection of secreted factors and signaling molecules phosphorylation. Human kidney proximal tubular epithelial cells, HKC-8, were stimulated with 176 stimuli. Supernatants were collected at 24 h and cell lysates at 5 and 25 min post stimulation. Supernatants or cell lysates were added to a mix containing magnetic beads internally dyed with precise proportions of red and infrared fluorophores, thus, rendering unique spectral signature microspheres. Each unique microsphere-bead was conjugated with a distinct monoclonal antibody against a secreted factor or a phosphoprotein. Biotinylated detection antibodies were added to the mix, followed by a streptavidin-R-Phycoerythrin complex. This process allows the simultaneous recognition of 32 secreted factors or 27 phosphoproteins in one sample. Created with <a href="http://BioRender.com" target="_blank">BioRender.com</a>, accessed on 1 June 2022.</p>
Full article ">Figure 2
<p>Differential expression of 32 secreted biological factors in the supernatants of human kidney proximal tubular epithelial cells (HKC-8) upon the stimulation with LPA (18:1) and 175 disparate biological stimuli. The expression was assessed with multiplex ELISA employing microbeads of unique spectral signatures conjugated with monoclonal antibodies specific for each of the 32 secreted factors. Red indicates active signals (FC ≥ 1.5). See also <a href="#app1-ijms-23-07452" class="html-app">Figure S1</a>.</p>
Full article ">Figure 3
<p>Phosphorylation of 27 major hubs in intracellular signaling pathways of human kidney proximal tubular epithelial cells (HKC-8) upon the stimulation with LPA (18:1) and 175 disparate biological stimuli. The expression was assessed with multiplex ELISA employing microbeads of unique spectral signatures conjugated with monoclonal antibodies specific for each of the 27 phosphoproteins. Red indicates active signals (FC ≥ 1.5). See also <a href="#app1-ijms-23-07452" class="html-app">Figure S1</a>.</p>
Full article ">Figure 4
<p>LPA stimulates the secretion of CCL2, CCL3, CXCL10, ICAM1, IL-6, and IL-8 from human kidney proximal tubular epithelial cells (HKC-8). Multiplex ELISA quantifying the expression of the indicated secreted factors in the supernatants from HKC-8 cells upon the stimulation with three different LPA species (16:0, 20:4, 18:1) at 10 μM for 24 h. Statistical significance was assessed with Brown–Forsythe’s and Welch’s ANOVA followed by Dunnett’s post hoc test in the case of normal distribution or with Kruskal–Wallis test in the case of non-normal distribution; * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001. Circles correspond to control values, squares correspond to LPA 16:0 values, upward triangles correspond to LPA 20:4 values and downward triangles correspond to LPA 18:1 values.</p>
Full article ">Figure 5
<p>LPA stimulates the phosphorylation of JUN, IκΒα, MEK1, ERK1, and CREB1 in human kidney proximal tubular epithelial cells (HKC-8). Cells were incubated with three different LPA species (16:0, 20:4, 18:1) at 10 μΜ for 5 (<b>A</b>) or 25 min (<b>B</b>), and the phosphorylation was assessed with multiplex ELISA in triplicates. Circles correspond to control values, squares correspond to LPA 16:0 values, upward triangles correspond to LPA 20:4 values and downward triangles correspond to LPA 18:1 values. Statistical significance was assessed with Brown–Forsythe’s and Welch’s ANOVA followed by Dunnett’s post hoc test in the case of normal distribution or with Kruskal–Wallis test in the case of non-normal distribution. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 6
<p><b>LPA clusters with proinflammatory stimuli</b><b>.</b> Heatmap of the active stimuli clustered in three major groups (1-3). Inactive stimuli and globally unresponsive signals were removed. Pairwise stimuli distance was calculated on binary transformed fold change values using Gower’s metric prior to divisive clustering. See also <a href="#app1-ijms-23-07452" class="html-app">Figures S2–S4</a>.</p>
Full article ">Figure 7
<p>LPA stimulates the expression of <span class="html-italic">CCL2</span>, <span class="html-italic">CCL3</span>, <span class="html-italic">CXCL8</span>, <span class="html-italic">CXCL10</span>, <span class="html-italic">ICAM1</span>, and <span class="html-italic">IL6</span> from human kidney proximal tubular epithelial cells (HKC-8). (<b>A</b>,<b>B</b>) HKC-8 cells were incubated for 1, 4, 12, and 24 h with 10 μM of LPA (<b>A</b>), and with 2.5, 5, and 10 μM LPA for 4 h (<b>B</b>). Control cells were stimulated with the equivalent volume of chloroform (VHC). mRNA-expression levels of the indicated secreted factors were quantified with RT-qPCR. The Cq values of each gene were normalized against the Cq values of <span class="html-italic">B2M</span>. The results represent the findings of two (<b>A</b>) and three (<b>B</b>) separate experiments. In (<b>A</b>) circles, upward triangles, downward triangles and diamonds refer to 1, 4, 12 and 24 hours of incubation with LPA, respectively. In (<b>B</b>) circles, upward triangles, downward triangles and diamonds refer to incubation with 0, 2.5, 5 and 10 μM LPA, respectively. Statistical significance was assessed in (<b>A</b>) with 2-way ANOVA and Tukey’s post hoc test and in (<b>B</b>) with Brown-Forsythe’s and Welch’s test or the Kruskal–Wallis test depending on the normality status of the data; * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, **** <span class="html-italic">p</span> &lt; 0.0001. See also <a href="#app1-ijms-23-07452" class="html-app">Figure S5</a>.</p>
Full article ">Figure 8
<p>Pharmacologic dissection of LPA-induced cellular signaling pathways. HKC-8 cells were pretreated for 1 h with 666-15 (CREB1 inhibitor) 10 μM in (<b>A</b>), JSH23 (NFκΒ inhibitor) 100 μM in (<b>B</b>), PD98059 (MEK/ERK inhibitor) 50 μM in (<b>C</b>), or SP600125 (JNK inhibitor) 50 μM in (<b>D</b>) and then activated with LPA at a final concentration of 10 μΜ for 4 h. mRNA-expression levels of the indicated secreted factors were quantified with RT-qPCR. The Cq values of each gene were normalized against the Cq values of <span class="html-italic">B2M</span>. Statistical analysis was performed with unpaired <span class="html-italic">t</span>-test or Welch’s test in the case of normal data and with Mann–Whitney in the case of non-normal data. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, **** <span class="html-italic">p</span> &lt; 0.0001. See also <a href="#app1-ijms-23-07452" class="html-app">Figure S6</a>.</p>
Full article ">Figure 9
<p>Graphical depiction of the LPA-induced signaling pathways in HKC-8 cells. LPA binds to the LPARs, which activate G proteins and the signal progresses to secondary signaling hubs, such as MEK/ERK or transcription factors c-JUN, CREB1, and NFκB. MEK/ERK, CREB1, and NFκB co-activate <span class="html-italic">CCL2</span>, <span class="html-italic">CCL3</span>, <span class="html-italic">CXCL8</span> (IL-8), and <span class="html-italic">ICAM1</span> expression. C-JUN activates only <span class="html-italic">CCL3</span> and <span class="html-italic">ICAM1</span> expression. Solid colored lines show connections that are derived from our results. Connections depicted with dashed lines are drawn from the literature and are not verified from our data. Created with <a href="http://BioRender.com" target="_blank">BioRender.com</a>, accessed on 1 June 2022.</p>
Full article ">
21 pages, 12733 KiB  
Article
Machine Learning Consensus Clustering of Morbidly Obese Kidney Transplant Recipients in the United States
by Charat Thongprayoon, Shennen A. Mao, Caroline C. Jadlowiec, Michael A. Mao, Napat Leeaphorn, Wisit Kaewput, Pradeep Vaitla, Pattharawin Pattharanitima, Supawit Tangpanithandee, Pajaree Krisanapan, Fawad Qureshi, Pitchaphon Nissaisorakarn, Matthew Cooper and Wisit Cheungpasitporn
J. Clin. Med. 2022, 11(12), 3288; https://doi.org/10.3390/jcm11123288 - 8 Jun 2022
Cited by 8 | Viewed by 2402
Abstract
Background: This study aimed to better characterize morbidly obese kidney transplant recipients, their clinical characteristics, and outcomes by using an unsupervised machine learning approach. Methods: Consensus cluster analysis was applied to OPTN/UNOS data from 2010 to 2019 based on recipient, donor, and transplant [...] Read more.
Background: This study aimed to better characterize morbidly obese kidney transplant recipients, their clinical characteristics, and outcomes by using an unsupervised machine learning approach. Methods: Consensus cluster analysis was applied to OPTN/UNOS data from 2010 to 2019 based on recipient, donor, and transplant characteristics in kidney transplant recipients with a pre-transplant BMI ≥ 40 kg/m2. Key cluster characteristics were identified using the standardized mean difference. Post-transplant outcomes, including death-censored graft failure, patient death, and acute allograft rejection, were compared among the clusters. Results: Consensus clustering analysis identified 3204 kidney transplant recipients with a BMI ≥ 40 kg/m2. In this cohort, five clinically distinct clusters were identified. Cluster 1 recipients were predominantly white and non-sensitized, had a short dialysis time or were preemptive, and were more likely to receive living donor kidney transplants. Cluster 2 recipients were older and diabetic. They were likely to have been on dialysis >3 years and receive a standard KDPI deceased donor kidney. Cluster 3 recipients were young, black, and had kidney disease secondary to hypertension or glomerular disease. Cluster 3 recipients had >3 years of dialysis and received non-ECD, young, deceased donor kidney transplants with a KDPI < 85%. Cluster 4 recipients were diabetic with variable dialysis duration who either received non-ECD standard KDPI kidneys or living donor kidney transplants. Cluster 5 recipients were young retransplants that were sensitized. One-year patient survival in clusters 1, 2, 3, 4, and 5 was 98.0%, 94.4%, 98.5%, 98.7%, and 97%, and one-year death-censored graft survival was 98.1%, 93.0%, 96.1%, 98.8%, and 93.0%, respectively. Cluster 2 had the worst one-year patient survival. Clusters 2 and 5 had the worst one-year death-censored graft survival. Conclusions: With the application of unsupervised machine learning, variable post-transplant outcomes are observed among morbidly obese kidney transplant recipients. Recipients with earlier access to transplant and living donation show superior outcomes. Unexpectedly, reduced graft survival in cluster 3 recipients perhaps underscores socioeconomic access to post-transplant support and minorities being disadvantaged in access to preemptive and living donor transplants. Despite obesity-related concerns, one-year patient and graft survival were favorable in all clusters, and obesity itself should be reconsidered as a hard barrier to kidney transplantation. Full article
(This article belongs to the Section Nephrology & Urology)
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) CDF plot displaying consensus distributions for each k. (<b>B</b>) Delta area plot reflecting the relative changes in the area under the CDF curve. (<b>C</b>) Consensus matrix heat map depicting consensus values on a white to blue color scale of each cluster.</p>
Full article ">Figure 2
<p>(<b>A</b>) The bar plot represents the mean consensus score for different numbers of clusters (k ranges from two to ten). (<b>B</b>) The PAC values assess ambiguously clustered pairs.</p>
Full article ">Figure 3
<p>(<b>A</b>) The standardized differences in cluster 1 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>B</b>) The standardized differences in cluster 2 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>C</b>) The standardized differences in cluster 3 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>D</b>) The standardized differences in cluster 4 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>E</b>) The standardized differences in cluster 5 of morbidly obese kidney transplant recipients for each of the baseline parameters. The x axis shows the standardized differences values, and the y axis shows baseline parameters. The dashed vertical lines represent the standardized differences cutoffs of &lt;−0.3 or &gt;0.3. Abbreviations: BMI: body mass index, CMV: cytomegalovirus, D: donor, DGF: delayed graft function, DM: diabetes mellitus, EBV: Epstein-Barr virus, ECD: extended criteria donor, ESKD: end-stage kidney disease, GN: glomerulonephritis, HBs: hepatitis B surface, HCV: hepatitis C virus, HIV: human immunodeficiency virus, HLA: human leukocyte antigen, HTN: hypertension, KDPI: kidney donor profile index, mTOR: mammalian target of rapamycin, PKD: polycystic kidney disease, PRA: panel reactive antibody, PVD: peripheral vascular disease, R: recipient.</p>
Full article ">Figure 3 Cont.
<p>(<b>A</b>) The standardized differences in cluster 1 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>B</b>) The standardized differences in cluster 2 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>C</b>) The standardized differences in cluster 3 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>D</b>) The standardized differences in cluster 4 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>E</b>) The standardized differences in cluster 5 of morbidly obese kidney transplant recipients for each of the baseline parameters. The x axis shows the standardized differences values, and the y axis shows baseline parameters. The dashed vertical lines represent the standardized differences cutoffs of &lt;−0.3 or &gt;0.3. Abbreviations: BMI: body mass index, CMV: cytomegalovirus, D: donor, DGF: delayed graft function, DM: diabetes mellitus, EBV: Epstein-Barr virus, ECD: extended criteria donor, ESKD: end-stage kidney disease, GN: glomerulonephritis, HBs: hepatitis B surface, HCV: hepatitis C virus, HIV: human immunodeficiency virus, HLA: human leukocyte antigen, HTN: hypertension, KDPI: kidney donor profile index, mTOR: mammalian target of rapamycin, PKD: polycystic kidney disease, PRA: panel reactive antibody, PVD: peripheral vascular disease, R: recipient.</p>
Full article ">Figure 3 Cont.
<p>(<b>A</b>) The standardized differences in cluster 1 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>B</b>) The standardized differences in cluster 2 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>C</b>) The standardized differences in cluster 3 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>D</b>) The standardized differences in cluster 4 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>E</b>) The standardized differences in cluster 5 of morbidly obese kidney transplant recipients for each of the baseline parameters. The x axis shows the standardized differences values, and the y axis shows baseline parameters. The dashed vertical lines represent the standardized differences cutoffs of &lt;−0.3 or &gt;0.3. Abbreviations: BMI: body mass index, CMV: cytomegalovirus, D: donor, DGF: delayed graft function, DM: diabetes mellitus, EBV: Epstein-Barr virus, ECD: extended criteria donor, ESKD: end-stage kidney disease, GN: glomerulonephritis, HBs: hepatitis B surface, HCV: hepatitis C virus, HIV: human immunodeficiency virus, HLA: human leukocyte antigen, HTN: hypertension, KDPI: kidney donor profile index, mTOR: mammalian target of rapamycin, PKD: polycystic kidney disease, PRA: panel reactive antibody, PVD: peripheral vascular disease, R: recipient.</p>
Full article ">Figure 3 Cont.
<p>(<b>A</b>) The standardized differences in cluster 1 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>B</b>) The standardized differences in cluster 2 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>C</b>) The standardized differences in cluster 3 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>D</b>) The standardized differences in cluster 4 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>E</b>) The standardized differences in cluster 5 of morbidly obese kidney transplant recipients for each of the baseline parameters. The x axis shows the standardized differences values, and the y axis shows baseline parameters. The dashed vertical lines represent the standardized differences cutoffs of &lt;−0.3 or &gt;0.3. Abbreviations: BMI: body mass index, CMV: cytomegalovirus, D: donor, DGF: delayed graft function, DM: diabetes mellitus, EBV: Epstein-Barr virus, ECD: extended criteria donor, ESKD: end-stage kidney disease, GN: glomerulonephritis, HBs: hepatitis B surface, HCV: hepatitis C virus, HIV: human immunodeficiency virus, HLA: human leukocyte antigen, HTN: hypertension, KDPI: kidney donor profile index, mTOR: mammalian target of rapamycin, PKD: polycystic kidney disease, PRA: panel reactive antibody, PVD: peripheral vascular disease, R: recipient.</p>
Full article ">Figure 3 Cont.
<p>(<b>A</b>) The standardized differences in cluster 1 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>B</b>) The standardized differences in cluster 2 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>C</b>) The standardized differences in cluster 3 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>D</b>) The standardized differences in cluster 4 of morbidly obese kidney transplant recipients for each of the baseline parameters. (<b>E</b>) The standardized differences in cluster 5 of morbidly obese kidney transplant recipients for each of the baseline parameters. The x axis shows the standardized differences values, and the y axis shows baseline parameters. The dashed vertical lines represent the standardized differences cutoffs of &lt;−0.3 or &gt;0.3. Abbreviations: BMI: body mass index, CMV: cytomegalovirus, D: donor, DGF: delayed graft function, DM: diabetes mellitus, EBV: Epstein-Barr virus, ECD: extended criteria donor, ESKD: end-stage kidney disease, GN: glomerulonephritis, HBs: hepatitis B surface, HCV: hepatitis C virus, HIV: human immunodeficiency virus, HLA: human leukocyte antigen, HTN: hypertension, KDPI: kidney donor profile index, mTOR: mammalian target of rapamycin, PKD: polycystic kidney disease, PRA: panel reactive antibody, PVD: peripheral vascular disease, R: recipient.</p>
Full article ">Figure 4
<p>(<b>A</b>) Patient survival and (<b>B</b>) death-censored graft survival after kidney transplant among five unique clusters of morbidly obese kidney transplant recipients in the USA.</p>
Full article ">
29 pages, 13212 KiB  
Article
Neuroanatomical and Immunohistological Study of the Main and Accessory Olfactory Bulbs of the Meerkat (Suricata suricatta)
by Mateo V. Torres, Irene Ortiz-Leal, Andrea Ferreiro, José Luis Rois and Pablo Sanchez-Quinteiro
Animals 2022, 12(1), 91; https://doi.org/10.3390/ani12010091 - 31 Dec 2021
Cited by 9 | Viewed by 4417
Abstract
We approached the study of the main (MOB) and accessory olfactory bulbs (AOB) of the meerkat (Suricata suricatta) aiming to fill important gaps in knowledge regarding the neuroanatomical basis of olfactory and pheromonal signal processing in this iconic species. Microdissection techniques [...] Read more.
We approached the study of the main (MOB) and accessory olfactory bulbs (AOB) of the meerkat (Suricata suricatta) aiming to fill important gaps in knowledge regarding the neuroanatomical basis of olfactory and pheromonal signal processing in this iconic species. Microdissection techniques were used to extract the olfactory bulbs. The samples were subjected to hematoxylin-eosin and Nissl stains, histochemical (Ulex europaeus agglutinin, Lycopersicon esculentum agglutinin) and immunohistochemical labelling (Gαo, Gαi2, calretinin, calbindin, olfactory marker protein, glial fibrillary acidic protein, microtubule-associated protein 2, SMI-32, growth-associated protein 43). Microscopically, the meerkat AOB lamination pattern is more defined than the dog’s, approaching that described in cats, with well-defined glomeruli and a wide mitral-plexiform layer, with scattered main cells and granular cells organized in clusters. The degree of lamination and development of the meerkat MOB suggests a macrosmatic mammalian species. Calcium-binding proteins allow for the discrimination of atypical glomerular subpopulations in the olfactory limbus between the MOB and AOB. Our observations support AOB functionality in the meerkat, indicating chemosensory specialization for the detection of pheromones, as identified by the characterization of the V1R vomeronasal receptor family and the apparent deterioration of the V2R receptor family. Full article
Show Figures

Figure 1

Figure 1
<p>Main macroscopic features of the vomeronasal system of the meerkat. (<b>A</b>) Cranioventral view of the palate allows the identification of the incisive papilla (IP) area. (<b>B</b>) The IP is visible after the removal of the mandible. (<b>C</b>) Transverse section of the nasal cavity at the level of the first premolar, showing the vomeronasal organ (VNO) at the base of the nasal septum (NS), on both sides of the vomer bone (right). (<b>D</b>) Dorsal view of a dissection of the OB. The skull has been removed and the frontal lobe has been extracted. The presumptive area of localization for the right accessory olfactory bulb is indicated (arrowhead). 1, Ethmoidal conchae; 2, Olfactory bulb; 3, Olfactory peduncle. (<b>E</b>) In the rostral view of the brain is visible the development of the olfactory bulbs (OB) and their topographical relationship with the frontal lobe of the telencephalon. (<b>F</b>) Ventral view of the brain showing the olfactory system of the meerkat: olfactory bulb (OB), olfactory peduncle (OP), olfactory tubercle (OT), and pyriform lobe (Py). (<b>G</b>) Dorsal view of the brain showing the longitudinal fissure of the telencephalon (LF) as well as the arrangement and relative size of the olfactory bulbs. (<b>H</b>) Medial view of the left hemiencephalon showing the following anatomical structures: corpus callosum (CC), interthalamic adhesion (IA), brainstem (BS), cerebellar vermis (CV), frontal lobe (FL), and olfactory bulb (OB). The black arrowhead points to the presumptive area of localization of the accessory olfactory bulb. a, anterior; d, dorsal; p, posterior; v, ventral.</p>
Full article ">Figure 2
<p>Transverse section of the main olfactory bulb of the meerkat stained by hematoxylin-eosin. From superficial to deep the following layers are identified: 1. Olfactory nerve layer (ONL), 2. Glomerular layer (GlL), 3. External plexiform layer (EPL), 4. Mitral layer (ML), 5. Internal plexiform layer (IPL), 6. Granular layer (GrL), 7. Subventricular zone (SVZ). d, dorsal; l, lateral; m, medial; v, ventral. Scale bars: 600 µm. Tv, Transverse.</p>
Full article ">Figure 3
<p>Sagittal sections of the olfactory bulbs of the meerkat stained with Hematoxylin-eosin. (<b>A</b>) Sagittal section of the rostral portion of the brain of the meerkat. The frontal lobe (FL), the main olfactory bulb (MOB), and the location, in the caudal part of the MOB, of the accessory olfactory bulb (AOB) are shown. (<b>B</b>) Higher magnification of the box in (<b>A</b>) showing the AOB. Following the course of the vomeronasal nerve throughout the sagittal histological series, we arrived at the area bordered by the dotted line that corresponds to the AOB. Its size is relatively small and its lamination, diffuse. It is better discriminated with the Nissl stain (<a href="#animals-12-00091-f004" class="html-fig">Figure 4</a> and <a href="#animals-12-00091-f005" class="html-fig">Figure 5</a>). (<b>C</b>) A more medial sagittal section than B shows the arrival of the vomeronasal nerve through the medial surface of the main olfactory bulb in direct topographical relationship to a large-caliber artery (Aa). Scale bars: (<b>A</b>): 600 µm. (<b>B</b>): 200 µm. (<b>C</b>): 100 µm. VNN, vomeronasal nerve, Sg, Sagittal.</p>
Full article ">Figure 4
<p>Histological study of the accessory olfactory bulb of the meerkat with Nissl staining. (<b>A</b>) Transverse section of the olfactory bulb showing the projection area of the accessory olfactory bulb (AOB) (delimited by dots), the lamination of the main olfactory bulb and the anterior olfactory nucleus (AON). The numbering of the layers is identical to that employed in <a href="#animals-12-00091-f002" class="html-fig">Figure 2</a>. (<b>B</b>) Enlargement of the AOB shown in A with its different layers numbered. 1, Vomeronasal nerve layer; 2, Glomerular layer; 3, Mitral-plexiform layer; 4, Granular layer. (<b>C</b>) Sagittal section of the olfactory bulb and the frontal lobe (FL) of the telencephalon showing the lamination of the main olfactory bulb (MOB) and the presence of the AOB in its caudomedial part. (<b>D</b>) Enlargement of the box in (<b>C</b>) showing the histology of the AOB. OV, olfactory ventricle. Scale bars: (<b>A</b>) 400 µm; (<b>B</b>) 200 µm; (<b>C</b>) 1200 µm; (<b>D</b>) 150 µm.</p>
Full article ">Figure 5
<p>Histological comparative study of the lamination of both the main and accessory olfactory bulbs. Lamination of the main olfactory bulb showed with HE (<b>A</b>) and Nissl staining (<b>B</b>): olfactory nerve layer (NL), glomerular layer (GlL), external plexiform layer (EPL), mitral layer (ML), internal plexiform layer (IPL), granular layer (GrL), subventricular zone (SVZ). The lamination of the accessory olfactory bulb is shown with HE (<b>C</b>) and Nissl staining (<b>D</b>): vomeronasal nerve layer (VNL), glomerular layer (GlL), mitral-plexiform layer (MPL) and granular layer (GrL). The small degree of differentiation of the accessory olfactory bulb glomeruli is mainly due to the scarcity of periglomerular cells. Only in a few cases (dotted line) is the usual spherical shape visible. The main cells of the AOB are diffusely distributed along the mitral-plexiform layer, especially in its deepest zone. They are oval or polyhedral in shape (black arrowhead). Granular cells are smaller and distributed in irregular clusters. Front lobe of the telencephalon (FL). Tv: transversal plane, Sg: sagittal plane. Scale bars: (<b>A</b>–<b>D</b>): 100 µm.</p>
Full article ">Figure 6
<p>Histological study with Nissl stain of the structure of the main olfactory bulb. (<b>A</b>) The glomerular layer (GlL) comprises the typical spherical glomeruli surrounded by numerous periglomerular cells. Scattered neurons with large somas are also found (arrowhead). (<b>B</b>) The granular layer (GrL) is formed by neat clusters of granule cells interspersed with large neuronal somas (arrowhead). (<b>C</b>) Mitral cells somas are aligned along the mitral layer (ML), whereas the external plexiform layer (EPL) contains tufted cells (arrowheads). (<b>D</b>) The deep area of the MOB contains the rostral horn of the lateral ventricle, the olfactory ventricle (OV), with its ependyma (arrow) and a dense proliferative zone characteristic of the subventricular zone (SVZ) neuroprogenitor cells. NL, nerve layer. Scale bars: (<b>A</b>,<b>B</b>) 50 µm; (<b>C</b>,<b>D</b>) 100 µm.</p>
Full article ">Figure 7
<p>Immunohistochemical study of Gαo, Gαi2 and OMP proteins in the main and accessory olfactory bulbs of the meerkat. (<b>A</b>,<b>C</b>) Anti-Gαi2 immunolabels specifically the accessory olfactory bulb (AOB). Transverse section (<b>A</b>) and hematoxylin counterstained sagittal section (<b>C</b>) show strong immunopositivity confined to the vomeronasal nerve and glomerular layers of the AOB (arrowheads in (<b>C</b>)) as well as in the vomeronasal nerve (VNN in (<b>A</b>)). (<b>B</b>,<b>D</b>) Anti-Gαo immunolabelling in transverse and sagittal sections of the OB consecutive to the previous one showing a positive response complementary to that described for anti-Gαi2. That is, labelling in the whole main olfactory bulb (MOB) and both the mitral-plexiform (MPL) and granular layers of the AOB and absence of labelling in the superficial layers of the AOB (arrowheads in (<b>D</b>)). The VNN is not immunolabelled. (<b>E</b>–<b>H</b>) Anti-OMP immunolabelling. (<b>E</b>) Transverse section of the whole OB shows immunoreactivity in the superficial layers of both the MOB and AOB. (<b>F</b>) Enlargement of the upper box in (<b>E</b>). The immunostaining is confined to the nerve and glomerular layers. (<b>G</b>) Enlargement of the lower box in (<b>E</b>). Within the glomeruli, only the nervous component is labelled. (<b>H</b>) Sagittal section of the AOB showing at more magnification how the immunolabelling comprises the nerve and glomerular layers (arrowheads). a, anterior; d, dorsal; l, lateral; v, ventral; m, medial; p, posterior; Sg, sagittal; Tv, transverse. Scale bars: (<b>A</b>,<b>C</b>,<b>F</b>,<b>H</b>) 200 µm; (<b>B</b>,<b>D</b>,<b>G</b>) 100 µm; (<b>E</b>) 400 µm.</p>
Full article ">Figure 8
<p>Immunohistochemical study of the olfactory bulb in meerkat (GAP-43, SMI-32 and MAP-2 markers). (<b>A</b>,<b>B</b>) Anti-GAP-43 produces in both transverse (<b>A</b>) and sagittal (<b>B</b>) sections a strong immunopositive labelling in the nerve, glomerular (+) and granular layers (Grl) of the AOB. (<b>D</b>) In the MOB Anti-GAP-43 marker showed immunopositivity in the ONL, IPL and GrL. (<b>C</b>,<b>E</b>) Anti-SMI-32 immunolabelling; hematoxylin counterstaining. This marker is immunonegative in the AOB, but it produces strong positivity in the principal cells of the MOB (arrowheads). (<b>F</b>) Anti-MAP-2 labels the mitral-plexiform and granular layers of the AOB (+) and the plexiform and mitral layers of the MOB. Sg: Sagittal; Tv, Transverse. Scale bars: (<b>A</b>,<b>C</b>,<b>E</b>,<b>F</b>) 100 µm; (<b>B</b>,<b>D</b>) 200 µm.</p>
Full article ">Figure 9
<p>Immunohistochemical labelling of the meerkat OB with anti-GFAP. (<b>A</b>) Anti-GFAP produces a strong labelling in the nerve layer of both the accessory and (<b>C</b>) main olfactory bulbs. The labelling in these layers corresponds to glial cell fibers, mainly ensheathing cells. (<b>B</b>) Enlargement of the box in (<b>A</b>) after hematoxylin counterstaining, showing fibers and astrocytes in the mitral-plexiform layer of the AOB (arrow). (<b>C</b>) In the MOB there is a remarkable presence of astrocytes in the superficial layers (arrows). Scale bars: (<b>A</b>,<b>C</b>) 100 µm; (<b>B</b>) 50 µm.</p>
Full article ">Figure 10
<p>Immunolabelling with anti-calbindin (CB) in the olfactory bulb of the meerkat. (<b>A</b>) Transverse section of the olfactory bulb counterstained with hematoxylin showing strong immunopositivity to CB in the vomeronasal nerve (VNN), and in the neuropil of both the nerve and glomerular layers of the accessory olfactory bulb (AOB). Additionally, immunopositive neurons are observed in the cerebral cortex of the frontal lobe (FL), and the anterior olfactory nucleus (AON). (<b>B</b>) Enlargement of the inset in (<b>A</b>), not counterstained, showing the strong immunopositivity of the VNN (arrow) and the immunolabelling pattern of the main olfactory bulb (MOB). The arrowheads point to positive periglomerular cells belonging to the glomeruli of the MOB. (<b>C</b>) Sagittal section confirming the CB-immunopositivity of the AOB in its glomerular and nerve layers. Immunopositive cells with multipolar (black arrowheads) and granular (open arrowheads) morphology are observed in the FL. (<b>D</b>) Hematoxylin counterstaining in the glomerular layer of the MOB shows that only a subpopulation of periglomerular cells is CB-immunopositive (open arrowheads). Scale bars: (<b>A</b>,<b>C</b>) 100 µm; (<b>B</b>,<b>D</b>) 50 µm.</p>
Full article ">Figure 11
<p>Anti-calretinin (CR) immunohistochemical study of the olfactory bulb in the meerkat. (<b>A</b>) Transverse section of the dorsomedial part of the olfactory bulb (OB) counterstained with hematoxylin. Strong immunopositivity can be seen in the accessory olfactory bulb (AOB), the vomeronasal nerve (VNN), and the glomeruli of the main olfactory bulb (MOB). (<b>B</b>) Enlargement of the left box in A, not counterstained. The immunolabelling of the AOB is concentrated in the nerve and glomerular layers and with less intensity in the mitral-plexiform and granular layers. Immunopositive mitral cells are identified in both the mitral-plexiform (black arrowhead) and granular layers (open arrowhead). (<b>C</b>) Enlargement of the area corresponding to the right box in A, but without counterstaining, showing the strong immunolabelling of the VNN and the presence in the dorsomedial part of the MOB of atypical CR-immunopositive glomeruli (+), in contrast to the typical CR-immunonegative glomeruli (−). A subpopulation of periglomerular cells were also immunopositive (arrowheads). (<b>D</b>) Sagittal section of the AOB confirming the positive immunolabelling pattern found in the transverse section. (<b>E</b>) Hematoxylin counterstained sagittal section of the AOB showing the density of immunopositive mitral cells in the mitral-plexiform layer (arrowheads) and isolated CR-positive granule cells in the granular layer (arrow). (<b>F</b>) Hematoxylin counterstained sagittal section of the MOB showing an atypical immunopositive glomerulus (+), surrounded by two immunonegative glomeruli (−). Immunopositive cells also appear in the artery accompanying the vomeronasal nerve (arrowheads). (<b>G</b>) Hematoxylin counterstained sagittal section of the MOB showing immunopositive mitral cells in the MOB (arrowhead). Scattered CR-immunopositive granule cells are interspersed among immunonegative granular clusters (arrows). FL, frontal lobe; Sg, sagittal; Tv, transversal. Scale bars: (<b>A</b>) 200 µm; (<b>B</b>–<b>F</b>) 100 µm; (<b>G</b>) 50 µm.</p>
Full article ">Figure 12
<p>Histochemical study of the meerkat olfactory bulb with the lectin <span class="html-italic">Lycopersicum esculentum</span> (LEA). (<b>A</b>) Staining in the nerve (open arrowhead) and glomerular (black arrowhead) layers of the main olfactory bulb (MOB). Analogous layers of the accessory olfactory bulb (AOB) (box) show a less intense staining. (<b>B</b>) Transverse section of the olfactory bulb confirming the positive staining in the nerve and glomerular layers of both the AOB (open arrowheads), and MOB (black arrowheads). (<b>C</b>) Enlargement of the box in A showing LEA staining in the superficial layers of the AOB. Sg, sagittal plane; Tv, transverse plane. Scale bars: (<b>A</b>) 600 µm; (<b>B</b>) 100 µm; (<b>C</b>) 50 µm.</p>
Full article ">
14 pages, 565 KiB  
Article
Soluble Complement Component 1q Receptor 1 (sCD93) Is Associated with Graft Function in Kidney Transplant Recipients
by Małgorzata Kielar, Paulina Dumnicka, Ewa Ignacak, Alina Będkowska-Prokop, Agnieszka Gala-Błądzińska, Barbara Maziarz, Piotr Ceranowicz and Beata Kuśnierz-Cabala
Biomolecules 2021, 11(11), 1623; https://doi.org/10.3390/biom11111623 - 2 Nov 2021
Cited by 1 | Viewed by 2075
Abstract
Cluster of differentiation 93 (CD93), also known as complement component 1q receptor 1 is a transmembrane glycoprotein expressed in endothelial and hematopoietic cells and associated with phagocytosis, cell adhesion, angiogenesis and inflammation. The extracellular part, soluble CD93 (sCD93), is released to body fluids [...] Read more.
Cluster of differentiation 93 (CD93), also known as complement component 1q receptor 1 is a transmembrane glycoprotein expressed in endothelial and hematopoietic cells and associated with phagocytosis, cell adhesion, angiogenesis and inflammation. The extracellular part, soluble CD93 (sCD93), is released to body fluids in inflammation. Data on sCD93 in kidney diseases are limited. Our aim was to evaluate serum sCD93 in long-term kidney transplant recipients as a marker of inflammation and endothelial dysfunction that may be potentially useful in early recognition of graft dysfunction. Seventy-eight adult patients with functioning kidney graft and stable clinical state were examined at least one year after kidney transplantation. Serum sCD93 was measured by enzyme immunosorbent assay. Estimated glomerular filtration rate (eGFR) and albuminuria or proteinuria were assessed at baseline and over one-year follow-up. Increased sCD93 was associated with lower baseline eGFR independently of the confounders. Moreover, sCD93 was negatively associated with eGFR during one-year follow-up in simple analysis; however, this was not confirmed after adjustment for confounders. Baseline sCD93 was positively associated with baseline albuminuria and with increased proteinuria during the follow-up. Serum sCD93 was not correlated with other studied inflammatory markers (interleukin 6, C-reactive protein, procalcitonin and C3 and C4 complement components). To the best of our knowledge, this is the first report regarding the concentrations of sCD93 in kidney transplant recipients and one of the first reports showing the inverse association between sCD93 and renal function. Serum sCD93 should be further evaluated as a diagnostic and prognostic marker in renal transplantation. Full article
(This article belongs to the Section Molecular Medicine)
Show Figures

Figure 1

Figure 1
<p>The association between serum concentrations of cluster of differentiation 93 (sCD93) and the baseline clinical characteristics of studied kidney transplant recipients: sex (<b>A</b>), first or second transplant (<b>B</b>), and the treatment with mammalian target of rapamycin (mTOR) inhibitors (<b>C</b>). Data are shown as median (line), interquartile range (box), and raw data (points); <span class="html-italic">p</span>-values in Mann–Whitney test are presented.</p>
Full article ">Figure 2
<p>The associations between baseline serum sCD93 and other studied inflammatory markers and the follow-up (FU) data: the association of sCD93 with the clinically significant transient (tr.) or persistent (pers.) graft injury (<b>A</b>); the association of sCD93 and urinary tract infection (UTI) during the follow-up (<b>B</b>); the associations of sCD93 (<b>C</b>) and complement component 4 (C4) (<b>D</b>) with increased proteinuria during the follow-up (i.e., at least A2 proteinuria that persisted or developed during the follow-up and was present at the end of observation). Data are shown as median (line), interquartile range (box), and raw data (points); <span class="html-italic">p</span>-values obtained using Kruskal–Wallis (<b>A</b>) and Mann–Whitney (<b>B</b>–<b>D</b>) test are presented.</p>
Full article ">
11 pages, 1972 KiB  
Article
Subtyping Hyperchloremia among Hospitalized Patients by Machine Learning Consensus Clustering
by Charat Thongprayoon, Voravech Nissaisorakarn, Pattharawin Pattharanitima, Michael A. Mao, Andrea G. Kattah, Mira T. Keddis, Carissa Y. Dumancas, Saraschandra Vallabhajosyula, Tananchai Petnak, Stephen B. Erickson, John J. Dillon, Vesna D. Garovic, Kianoush B. Kashani and Wisit Cheungpasitporn
Medicina 2021, 57(9), 903; https://doi.org/10.3390/medicina57090903 - 30 Aug 2021
Cited by 8 | Viewed by 2639
Abstract
Background and Objectives: Despite the association between hyperchloremia and adverse outcomes, mortality risks among patients with hyperchloremia have not consistently been observed among all studies with different patient populations with hyperchloremia. The objective of this study was to characterize hyperchloremic patients at [...] Read more.
Background and Objectives: Despite the association between hyperchloremia and adverse outcomes, mortality risks among patients with hyperchloremia have not consistently been observed among all studies with different patient populations with hyperchloremia. The objective of this study was to characterize hyperchloremic patients at hospital admission into clusters using an unsupervised machine learning approach and to evaluate the mortality risk among these distinct clusters. Materials and Methods: We performed consensus cluster analysis based on demographic information, principal diagnoses, comorbidities, and laboratory data among 11,394 hospitalized adult patients with admission serum chloride of >108 mEq/L. We calculated the standardized mean difference of each variable to identify each cluster’s key features. We assessed the association of each hyperchloremia cluster with hospital and one-year mortality. Results: There were three distinct clusters of patients with admission hyperchloremia: 3237 (28%), 4059 (36%), and 4098 (36%) patients in clusters 1 through 3, respectively. Cluster 1 was characterized by higher serum chloride but lower serum sodium, bicarbonate, hemoglobin, and albumin. Cluster 2 was characterized by younger age, lower comorbidity score, lower serum chloride, and higher estimated glomerular filtration (eGFR), hemoglobin, and albumin. Cluster 3 was characterized by older age, higher comorbidity score, higher serum sodium, potassium, and lower eGFR. Compared with cluster 2, odds ratios for hospital mortality were 3.60 (95% CI 2.33–5.56) for cluster 1, and 4.83 (95% CI 3.21–7.28) for cluster 3, whereas hazard ratios for one-year mortality were 4.49 (95% CI 3.53–5.70) for cluster 1 and 6.96 (95% CI 5.56–8.72) for cluster 3. Conclusions: Our cluster analysis identified three clinically distinct phenotypes with differing mortality risks in hospitalized patients with admission hyperchloremia. Full article
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) CDF plot displaying consensus distributions for each k; (<b>B</b>) Delta area plot reflecting the relative changes in the area under the CDF curve.</p>
Full article ">Figure 2
<p>Consensus matrix heat map depicting consensus values on a white to blue color scale of each cluster.</p>
Full article ">Figure 3
<p>(<b>A</b>)The bar plot represents the mean consensus score for different numbers of clusters (k ranges from two to ten); (<b>B</b>) The PAC values assess ambiguously clustered pairs.</p>
Full article ">Figure 4
<p>The standardized differences across three clusters for each of the baseline parameters. The <span class="html-italic">x</span> axis is the standardized differences value, and the <span class="html-italic">y</span> axis shows baseline parameters. The dashed vertical lines represent the standardized differences cutoffs of &lt;−0.3 or &gt;0.3. Abbreviations: AKI, acute kidney injury; DM, diabetes mellitus; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; PVD, peripheral vascular disease; CHF, congestive heart failure; MI, myocardial infarction; BMI, body mass index; Hb, hemoglobin; SID, strong ion difference; AG, anion gap; ESKD, end stage kidney disease; HCO3, bicarbonate; Cl, chloride; K, potassium; Na, sodium; GFR, glomerular filtration rate; RS, respiratory system; ID, infectious disease; GI, gastrointestinal.</p>
Full article ">Figure 5
<p>(A) Hospital mortality among different clusters of admission Hyperchloremia; (B) One-year mortality among different clusters of admission hyperchloremia.</p>
Full article ">
20 pages, 1525 KiB  
Review
Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know
by Yukako Ohyama, Matthew B. Renfrow, Jan Novak and Kazuo Takahashi
J. Clin. Med. 2021, 10(16), 3467; https://doi.org/10.3390/jcm10163467 - 5 Aug 2021
Cited by 30 | Viewed by 5252
Abstract
IgA nephropathy (IgAN), the most common primary glomerular disease worldwide, is characterized by glomerular deposition of IgA1-containing immune complexes. The IgA1 hinge region (HR) has up to six clustered O-glycans consisting of Ser/Thr-linked N-acetylgalactosamine usually with β1,3-linked galactose and variable sialylation. [...] Read more.
IgA nephropathy (IgAN), the most common primary glomerular disease worldwide, is characterized by glomerular deposition of IgA1-containing immune complexes. The IgA1 hinge region (HR) has up to six clustered O-glycans consisting of Ser/Thr-linked N-acetylgalactosamine usually with β1,3-linked galactose and variable sialylation. Circulating levels of IgA1 with abnormally O-glycosylated HR, termed galactose-deficient IgA1 (Gd-IgA1), are increased in patients with IgAN. Current evidence suggests that IgAN is induced by multiple sequential pathogenic steps, and production of aberrantly glycosylated IgA1 is considered the initial step. Thus, the mechanisms of biosynthesis of aberrantly glycosylated IgA1 and the involvement of aberrant glycoforms of IgA1 in disease development have been studied. Furthermore, Gd-IgA1 represents an attractive biomarker for IgAN, and its clinical significance is still being evaluated. To elucidate the pathogenesis of IgAN, it is important to deconvolute the biosynthetic origins of Gd-IgA1 and characterize the pathogenic IgA1 HR O-glycoform(s), including the glycan structures and their sites of attachment. These efforts will likely lead to development of new biomarkers. Here, we review the IgA1 HR O-glycosylation in general and the role of aberrantly glycosylated IgA1 in the pathogenesis of IgAN in particular. Full article
(This article belongs to the Special Issue New Insights into the Pathogenesis and Therapies of IgA Nephropathy)
Show Figures

Figure 1

Figure 1
<p>Molecular structure of IgA and its glycosylation sites. (<b>a</b>) Human IgA has two subclasses: IgA1 and IgA2. IgA1 harbors clustered <span class="html-italic">O</span>-glycans in its hinge region. IgA1 and IgA2 have several <span class="html-italic">N</span>-glycans in their constant region of heavy chains. IgA1 has two <span class="html-italic">N</span>-glycosylation sites at asparagine (Asn)<sup>263</sup> and Asn<sup>459</sup>. Three allotypes of IgA2 are known, designated A2m (1), A2m (2), and IgA2 (n). All allotypes have <span class="html-italic">N</span>-glycans at Asn<sup>166</sup>, Asn<sup>263</sup>, Asn<sup>337</sup>, and Asn<sup>459</sup>. A2m (2) and IgA2 (n) allotypes have a fifth <span class="html-italic">N</span>-glycan at Asn<sup>211</sup> [<a href="#B45-jcm-10-03467" class="html-bibr">45</a>]. (<b>b</b>,<b>c</b>) Schematic representation of dimeric IgA1 and secretory IgA1. Both the joining chain (J chain) and the secretory component have <span class="html-italic">N</span>-glycan(s). Fab, antigen-binding fragment.</p>
Full article ">Figure 2
<p>Schematic representation of human IgA1. The IgA1 heavy chain has three to six <span class="html-italic">O</span>-glycans in its hinge region (HR) and two <span class="html-italic">N</span>-glycosylation sites [<a href="#B46-jcm-10-03467" class="html-bibr">46</a>,<a href="#B54-jcm-10-03467" class="html-bibr">54</a>]. There are nine potential <span class="html-italic">O</span>-glycosylation sites, marked in red font, of which up to six sites can be <span class="html-italic">O</span>-glycosylated (underlined serine (Ser) and threonine (Thr)). Ser/Thr in italic (230, 233, 236) show the frequent sites with galactose (Gal)-deficient <span class="html-italic">O</span>-glycan (<b>a</b>) [<a href="#B50-jcm-10-03467" class="html-bibr">50</a>,<a href="#B52-jcm-10-03467" class="html-bibr">52</a>,<a href="#B53-jcm-10-03467" class="html-bibr">53</a>,<a href="#B55-jcm-10-03467" class="html-bibr">55</a>]. There are <span class="html-italic">O</span>-glycan variants of circulatory IgA1. <span class="html-italic">N</span>-acetylgalactosamine (GalNAc) is attached to Ser/Thr residues and can be extended by the attachment of Gal to GalNAc residues. GalNAc or Gal or both can be sialylated. Due of diversity of the glycan attachment sites, the number of <span class="html-italic">O</span>-glycans in HR, and variability of <span class="html-italic">O</span>-glycan structures, IgA1-HR <span class="html-italic">O</span>-glycoforms exhibit wide heterogeneity. Gd-IgA1-specific antibodies are considered to recognize Gal-deficient IgA1 glycoforms with terminal GalNAc (left structure). NeuAc, <span class="html-italic">N</span>-acetylneuraminic acid (<b>b</b>).</p>
Full article ">Figure 3
<p><span class="html-italic">O</span>-Glycosylation pathways of the human IgA1 hinge region (HR). The biosynthesis process starts with the attachment of <span class="html-italic">N</span>-acetylgalactosamine (GalNAc) to Ser/Thr residues in the HR by UDP-GalNAc-transferase 2 (GalNAc-T2). GalNAc residues are extended by galactose or <span class="html-italic">N</span>-acetylneuraminic acid (NeuAc) by core 1 β1,3-galactosyltransferase (C1GalT1) and its molecular chaperone Cosmc or α2,6 sialyltransferase (ST6GalNAc2), respectively. Finally, the <span class="html-italic">O</span>-glycan structure is completed by attachment of NeuAc to the galactose residue and/or GalNAc residues, each of which is mediated by α2,3-sialyltransferase (ST3Gal1) and ST6GalNAc2. The sialylation of GalNAc before the attachment of galactose prevents galactosylation of GalNAc (marked by *) [<a href="#B62-jcm-10-03467" class="html-bibr">62</a>].</p>
Full article ">Figure 4
<p>Macromolecular forms of IgA1. Although mesangially deposited IgA1 has not been fully characterized, Gd-IgA1-IgG (or IgA) immune complexes, IgA-IgA receptor complexes, self-aggregated IgA1 proteins, other serum protein complexes with IgA1, and secretory IgA1 are possible forms in the kidney deposits [<a href="#B23-jcm-10-03467" class="html-bibr">23</a>]. Dimeric IgA1 is composed of two monomeric IgA1 connected by joining chain (J chain) (<b>a</b>). Larger molecular forms of IgA1 may include complexes/aggregates of dimeric IgA1 and monomeric IgA1. Aberrantly glycosylated IgA1 may be prone to aggregation [<a href="#B127-jcm-10-03467" class="html-bibr">127</a>]. (<b>b</b>). Incomplete galactosylation of <span class="html-italic">O</span>-glycans in the IgA1 hinge region results in the exposure of terminal GalNAc and is recognized by autoantibodies (IgG of IgA), leading to the formation of IgA1-containing immune complexes (<b>c</b>). IgA1 complexes with soluble CD89 (sCD89) may be formed from CD89 cleaved from the surface of monocytes/macrophages (<b>d</b>). Secretory IgA1 consists of dimeric IgA1 with J chain and the secretory component (<b>e</b>). These macromolecular IgA1 forms (<b>a</b>–<b>e</b>) can form complexes with other serum proteins.</p>
Full article ">Figure 5
<p>Detection of galactose-deficient IgA1 (Gd-IgA1). Serum Gd-IgA1 levels measured by <span class="html-italic">Helix aspersa</span> agglutinin (HAA)-based ELISA, due to HAA specificity for terminal GalNAc, is significantly higher in patients with IgAN than in healthy subjects (<b>a</b>) [<a href="#B32-jcm-10-03467" class="html-bibr">32</a>,<a href="#B33-jcm-10-03467" class="html-bibr">33</a>]. The left figure of (<b>a</b>) was published in <span class="html-italic">Kidney International</span> 2007, 71, 1148-54, Moldoveanu, Z. et al., Copyright 2007 Elsevier Inc and is republished with permission. The right figure of (<b>a</b>) is republished with permission of Oxford University Press, from <span class="html-italic">Nephrology Dialysis Transplantation</span> 2008, 23, 1931-9, Shimozato, S. et al., Copyright 2008 Oxford University Press. Detection of Gd-IgA1 using monoclonal antibody against human Gd-IgA1 hinge region (HR) peptide (<b>b</b>) [<a href="#B154-jcm-10-03467" class="html-bibr">154</a>]. The figure (<b>b</b>) was published in <span class="html-italic">Journal of Nephrology</span> 2015, 28, 181-6, Hiki, Y. et al., Copyright 2014, The Author(s). This article is under the terms of the Creative Commons CC BY license. A variety of IgA1 HR <span class="html-italic">O</span>-glycoforms can be detected by high-resolution mass spectrometry according to the difference in mass arising from the number of attached monosaccharides to the amino acid backbone of the IgA1 HR (His<sup>208</sup>-Arg<sup>245</sup>). The number of <span class="html-italic">N</span>-acetylgalactosamine (GalNAc; □) and galactose (Gal; ●) are shown above the individual peaks (<b>c</b>).</p>
Full article ">
Back to TopTop